09-Sep-2010 | business & finance
Prima Biomed and Bioceros announce licensing agreement for Cripto-1 cancer immunotherapy treatment
Prima BioMed Ltd announced that its subsidiary company, Oncomab Pty Ltd has entered into a licensing agreement for the development of a Cripto-1 cancer ...
